Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$239.75 - $277.0 $314,072 - $362,870
-1,310 Reduced 53.8%
1,125 $283,000
Q4 2022

Feb 06, 2023

SELL
$241.42 - $282.29 $24,142 - $28,229
-100 Reduced 3.94%
2,435 $646,000
Q3 2022

Nov 09, 2022

SELL
$247.06 - $1507.4 $206,295 - $1.26 Million
-835 Reduced 24.78%
2,535 $655,000
Q2 2022

Aug 08, 2022

SELL
$237.11 - $299.66 $33,906 - $42,851
-143 Reduced 4.07%
3,370 $854,000
Q1 2022

May 05, 2022

BUY
$257.27 - $315.76 $96,476 - $118,410
375 Added 11.95%
3,513 $1.03 Million
Q4 2021

Feb 24, 2022

BUY
$292.08 - $329.01 $916,547 - $1.03 Million
3,138 New
3,138 $1.03 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Compass Financial Advisors LLC Portfolio

Follow Compass Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Financial Advisors LLC with notifications on news.